Deaths attributable to carbapenem-resistant Enterobacteriaceae infections
- PMID: 24959688
- PMCID: PMC4073868
- DOI: 10.3201/eid2007.121004
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections
Abstract
We evaluated the number of deaths attributable to carbapenem-resistant Enterobacteriaceae by using studies from around the world published before April 9, 2012. Attributable death was defined as the difference in all-cause deaths between patients with carbapenem-resistant infections and those with carbapenem-susceptible infections. Online databases were searched, and data were qualitatively synthesized and pooled in a metaanalysis. Nine studies met inclusion criteria: 6 retrospective case-control studies, 2 retrospective cohort studies, and 1 prospective cohort study. Klebsiella pneumoniae was the causative pathogen in 8 studies; bacteremia was the only infection in 5 studies. We calculated that 26%-44% of deaths in 7 studies were attributable to carbapenem resistance, and in 2 studies, which included bacteremia and other infections, -3% and -4% of deaths were attributable to carbapenem resistance. Pooled outcomes showed that the number of deaths was significantly higher in patients with carbapenem-resistant infections and that the number of deaths attributable to carbapenem resistance is considerable.
Keywords: Enterobacteriaceae; KPC; Klebsiella pneumoniae; Klebsiella pneumoniae carbapenemase; attributable deaths; attributable mortality; bacteremia; bacteria; bloodstream infection; carbapenem resistance; carbapenem-resistant Enterobacteriaceae; carbapenemase-producing; carbapenemases; deaths; infections; meta-analysis; metaanalysis; mortality; outcome; systematic review.
Figures
Similar articles
-
Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.Clin Infect Dis. 2017 Feb 1;64(3):257-264. doi: 10.1093/cid/ciw741. Epub 2016 Nov 9. Clin Infect Dis. 2017. PMID: 28013264 Free PMC article.
-
Health outcomes attributable to carbapenemase-producing Enterobacteriaceae infections: A systematic review and meta-analysis.Infect Control Hosp Epidemiol. 2020 Jan;41(1):37-43. doi: 10.1017/ice.2019.282. Epub 2019 Oct 22. Infect Control Hosp Epidemiol. 2020. PMID: 31637986
-
Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.Infect Control Hosp Epidemiol. 2009 Oct;30(10):972-6. doi: 10.1086/605922. Infect Control Hosp Epidemiol. 2009. PMID: 19712030
-
Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies.Emerg Microbes Infect. 2016 Mar 23;5(3):e27. doi: 10.1038/emi.2016.22. Emerg Microbes Infect. 2016. PMID: 27004762 Free PMC article. Review.
-
Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis.Infect Control Hosp Epidemiol. 2017 Nov;38(11):1319-1328. doi: 10.1017/ice.2017.197. Epub 2017 Sep 27. Infect Control Hosp Epidemiol. 2017. PMID: 28950924 Review.
Cited by
-
Accelerating innovation in rapid diagnostics and targeted antibacterials.Nat Biotechnol. 2015 Jun;33(6):589-90. doi: 10.1038/nbt.3251. Nat Biotechnol. 2015. PMID: 26057972 No abstract available.
-
Ceftazidime-Avibactam as a Salvage Treatment for Severely Infected Immunosuppressed Children.Drug Des Devel Ther. 2024 Jul 30;18:3399-3413. doi: 10.2147/DDDT.S467967. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39100219 Free PMC article.
-
Leclercia adecarboxylata From Human Gut Flora Carries mcr-4.3 and bla IMP-4-Bearing Plasmids.Front Microbiol. 2019 Dec 5;10:2805. doi: 10.3389/fmicb.2019.02805. eCollection 2019. Front Microbiol. 2019. PMID: 31866974 Free PMC article.
-
Public Health Efforts Can Impact Adoption of Current Susceptibility Breakpoints, but Closer Attention from Regulatory Bodies Is Needed.J Clin Microbiol. 2019 Feb 27;57(3):e01488-18. doi: 10.1128/JCM.01488-18. Print 2019 Mar. J Clin Microbiol. 2019. PMID: 30567751 Free PMC article.
-
Ceftazidime-Avibactam as Salvage Treatment for Infections Due to Carbapenem-Resistant Klebsiella pneumoniae in Liver Transplantation Recipients.Infect Drug Resist. 2021 Dec 21;14:5603-5612. doi: 10.2147/IDR.S342163. eCollection 2021. Infect Drug Resist. 2021. PMID: 34992387 Free PMC article.
References
-
- Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E, Skoutelis A, et al. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother. 2009;53:1868–73 .10.1128/AAC.00782-08 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
